Prevalence of Sarcopenia and Its Geriatric Features

The goal of this study is to determine the prevalence of sarcopenia in a geriatric hospital ward.

Sarcopenia is defined by a loss of muscle mass, loss of muscle strength and loss of muscle quality. It is a geriatric syndrome that, to this date, is not systematically tracked in clinical practice.

In order to detect sarcopenia, the investigators will use the operational definition proposed by the European Working Group (EWGSOP) involving the measure of three parameters, namely the speed of walking, the muscle strength and the measurement of the muscular mass.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sarcopenia Atrophy Muscular Atrophy Nervous System Diseases Neurologic Manifestations Neuromuscular Manifestations Pathological Conditions, Anatomical Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Brugmann

Brussels, 1020, Belgium

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

To be admitted in the unit 83 of the Geriatric Departement of the CHU Brugmann hospital, from 10/01/2016 till 30/03/2017.

Exclusion criteria

Patients unable to consent or without representatives
Patients unable to perform the hand- grip test, the walk test or measurement of the body components by DEXA
Patients in severe pain
Bedridden patients
Patients for which a clear therapeutic abstention has been established
Language barriere that cannot be overcome
Patients unable to walk without the help of a third person

Treatment and study plan

Sarcopenia detection

Other

The assessment of sarcopenia is performed according to the recommendations of the EWGSOP (European Working Group on Sarcopenia in Older people). Three measurements are made:

Muscle mass measurement by dual energy X-ray absorptiometry (DEXA).
Walking speed measurement
Hand grip test

A diagnosis of sarcopenia is established if the walking speed is inferior to 0.8 m/sec, the muscular strength is low and the muscular mass is low.

Data regarding the geriatric characteristics of this sarcopenic population will be collected.

Primary outcomes

Prevalence of sarcopenia

Time frame: From 10/01/2016 till 30/03/2017 (up to 15 months)

Sarcopenia detection will be performed at the end of each hospitalization stay in unit 83 of the CHU Brugmann Hospital (Geriatry Department)

Secondary outcomes

Percentage of hospitalized patients unable to perform the sarcopenia detection test

Time frame: From 10/01/2016 till 30/03/2017 (up to 15 months)

Systematic retrospective review of patients hospitalised in the geriatric ward of the CHU Brugmann hospital during the length of the study, in order to determine the percentage of patients that could not, because of one of more exclusion criteria, perform the sarcopenia detection test.

Sponsors and collaborators

Lead sponsor

Brugmann University Hospital

Other

Registry information

Important dates

Study start: 2016
Primary completion: 2018
Study completion: 2018
First posted: Jan 27, 2016
Registry last updated: Jan 26, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed